Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: A randomized controlled trial

被引:89
作者
St-Onge M.P. [1 ]
Farnworth E.R. [2 ]
Savard T. [2 ]
Chabot D. [2 ]
Mafu A. [2 ]
Jones P.J.H. [1 ]
机构
[1] School of Dietetics/Human Nutrition, McGill University, Montreal, Que., Ste-Anne-de-Bellevue
[2] Food Research and Development Center, Agriculture Canada
来源
BMC Complementary and Alternative Medicine | / 2卷 / 1期
关键词
Short Chain Fatty Acid; Cholesterol Synthesis; Fermented Milk; Supplementation Period; Plasma Cholesterol Concentration;
D O I
10.1186/1472-6882-2-1
中图分类号
学科分类号
摘要
Background: Fermented milk products have been shown to affect serum cholesterol concentrations in humans. Kefir, a fermented milk product, has been traditionally consumed for its potential health benefits but has to date not been studied for its hypocholesterolemic properties. Methods: Thirteen healthy mildly hypercholesterolemic male subjects consumed a dairy supplement in randomized crossover trial for 2 periods of 4 wk each. Subjects were blinded to the dairy supplement consumed. Blood samples were collected at baseline and after 4 wk of supplementation for measurement of plasma total, low-density lipoprotein, and high-density lipoprotein cholesterol and triglyceride concentrations, as well as fatty acid profile and cholesterol synthesis rate. Fecal samples were collected at baseline and after 2 and 4 wk of supplementation for determination of fecal short chain fatty acid level and bacterial content. Results: Kefir had no effect on total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglyceride concentrations nor on cholesterol fractional synthesis rates after 4 wk of supplementation. No significant change on plasma fatty acid levels was observed with diet. However, both kefir and milk increased (p < 0.05) fecal isobutyric, isovaleric and propionic acids as well as the total amount of fecal short chain fatty acids. Kefir supplementation resulted in increased fecal bacterial content in the majority of the subjects. Conclusions: Since kefir consumption did not result in lowered plasma lipid concentrations, the results of this study do not support consumption of kefir as a cholesterol-lowering agent. © 2002 St-Onge et al; license BioMed Central Ltd.
引用
收藏
页数:7
相关论文
共 27 条
[1]  
Koroleva N.S., Technology of kefir and kumys, Fed. Int. Laiterie Int. Dairy Fed. Bull., 227, pp. 96-100, (1988)
[2]  
Farnworth E.R., Kefir: From folklore to regulatory approval, J. Nutraceut. Functional & Medical Fd., 1, pp. 57-68, (1999)
[3]  
Akalin A.S., Gonc S., Duzel S., Influence of yogurt and acidophilus yogurt on serum cholesterol levels in mice, J. Dairy Sci., 80, pp. 2721-2725, (1997)
[4]  
Beena A., Prasad V., Effect of yogurt and bifidus yogurt fortified with skim milk powder, condensed whey and lactose-hydrolyzed condensed whey on serum cholesterol and triacylglycerol levels in rats, J. Dairy Res., 64, pp. 453-457, (1997)
[5]  
Gilliland S.E., Speck M.L., Deconjugation of bile acids by intestinal Lactobacilli, Appl. Environ. Microbiol., 33, pp. 15-18, (1977)
[6]  
Nakajima H., Suzuki Y., Hirota T., Cholesterol-lowering activity of ropy fermented milk, J. Food Sci., 57, pp. 1327-1329, (1992)
[7]  
Rao D.R., Chawan C.B., Pulusani S.R., Influence of milk and thermophilus milk on plasma cholesterol and hepatic cholesterogenesis in rats, J. Food Sci., 46, pp. 1339-1341, (1981)
[8]  
Agaerbaeck M., Gerdes L.U., Richelsen B., Hypocholesterolemic effect of a new fermented milk product in healthy middle-aged men, Eur. J. Clin. Nutr., 49, pp. 346-352, (1995)
[9]  
Hepner G., Fried R., St. Jeor S., Fusetti L., Morin R., Hypocholesterolemic effect of yogurt and milk, Am. J. Clin. Nutr., 32, pp. 19-24, (1979)
[10]  
Richelsen B., Kristensen K., Pedersen S.B., Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins - A placebo-controlled and double blind study, Eur. J. Clin. Nutr., 50, pp. 811-815, (1996)